FindTrial
Sign In

To check the failure rate of matured arteriovenous fistula which is used for dialysis.

Surveillance to assess the secondary failure of matured arteriovenous fistula

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025553
Enrollment
64
Registered
2020-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Sponsors

Department of Nephrology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient who are CKD 4/5 who are having arteriovenous fistula

Exclusion criteria

Exclusion criteria: VASCULAR GANGRENE

Design outcomes

Primary

MeasureTime frame
To assess the secondary failure rate of matured arteriovenous fistulaTimepoint: at 3rd month and at 6th month after arteriovenous fistula creation—

Secondary

MeasureTime frame
To assess the sensitivity and specificity of methods used to for assessing the arteriovenous fistula i.e. clinical examination doppler ultrasound and fistulogramTimepoint: at 3rd month and at 6th month after arteriovenous fistula creation—

Countries

India

Contacts

Public ContactDR MANOJPRABHAKARAN

ABVIMS DRRML HOSPITAL

hsmnephro@gmail.com9968474805

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026